- Report
- June 2025
- 150 Pages
Global
From €3384EUR$3,850USD£2,950GBP
€4264EUR$4,850USD£3,716GBP
- Report
- June 2025
- 150 Pages
Global
From €3384EUR$3,850USD£2,950GBP
€4264EUR$4,850USD£3,716GBP
- Report
- April 2025
- 150 Pages
Global
From €3384EUR$3,850USD£2,950GBP
€4264EUR$4,850USD£3,716GBP
- Report
- March 2025
- 150 Pages
Global
From €3384EUR$3,850USD£2,950GBP
€4264EUR$4,850USD£3,716GBP
- Report
- March 2025
- 150 Pages
Global
From €3384EUR$3,850USD£2,950GBP
€4264EUR$4,850USD£3,716GBP
- Report
- March 2025
- 150 Pages
Global
From €3384EUR$3,850USD£2,950GBP
€4264EUR$4,850USD£3,716GBP
- Report
- February 2025
- 150 Pages
Global
From €3384EUR$3,850USD£2,950GBP
€4264EUR$4,850USD£3,716GBP
- Directory
- December 2025
Global
From €1714EUR$1,950USD£1,494GBP
- Report
- April 2025
- 220 Pages
Global
From €1756EUR$1,997USD£1,530GBP
- Newsletter
- December 2025
Global
€2633EUR$2,995USD£2,295GBP
- Report
- November 2025
- 135 Pages
Global
From €3624EUR$4,123USD£3,159GBP
€4264EUR$4,850USD£3,716GBP
- Report
- October 2025
- 80 Pages
Global
From €4264EUR$4,850USD£3,716GBP
- Report
- October 2025
- 89 Pages
Global
From €4264EUR$4,850USD£3,716GBP
- Report
- August 2025
- 115 Pages
Global
From €3033EUR$3,450USD£2,643GBP
- Report
- June 2025
- 193 Pages
Global
From €4351EUR$4,950USD£3,793GBP
- Report
- June 2025
- 105 Pages
Global
From €3033EUR$3,450USD£2,643GBP
- Report
- June 2025
- 180 Pages
Global
From €2813EUR$3,200USD£2,452GBP
€3516EUR$4,000USD£3,065GBP
- Report
- February 2025
- 135 Pages
Global
From €3624EUR$4,123USD£3,159GBP
€4264EUR$4,850USD£3,716GBP
- Report
- January 2025
- 50 Pages
Global
From €2197EUR$2,499USD£1,915GBP
- Report
- January 2025
- 120 Pages
Global
€4990EUR$6,081USD£4,501GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more